COX inhibitor Phenylbutazone, Purity ≥98%

Cat. No.: X23-10-ZQ509

COX inhibitor Phenylbutazone, Purity ≥98%

Synonym: Phenylbutazone; 50-33-9; 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione; Butapirazol; Butazolidin; Butadion; Diphenylbutazone; COX inhibitor

  • MDL: MFCD00005500
  • CAS Number: 50-33-9
  • Compound CID: 4781
Product Size
0.5 g; 1 g; 5 g; 10 g; 25 g
Price
Datasheet
MSDS
Properties
Description
Phenylbutazone, soluble in DMSO and ethanol and insoluble in water, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Weight
308.38
Molecular Formula
C19H20N2O2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 55 mg/mL (178.35 mM); Water: Insoluble; Ethanol: 55 mg/mL (178.35 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Phenylbutazone can be used to explore its anti-inflammatory and analgesic properties in the treatment of pain and inflammation.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.